School of Medicine
Showing 1-42 of 42 Results
-
Asuka Eguchi
Postdoctoral Scholar, Microbiology and Immunology - Baxter Labs
BioAsuka Eguchi, PhD is a postdoctoral fellow working with Helen Blau, PhD at Stanford University. Her interests lie in understanding how cells sense and respond to genotoxic stress. Currently, she is developing therapeutic strategies to combat heart failure in Duchenne muscular dystrophy. Dr. Eguchi received her BS in Biology at the University of Alabama in Huntsville. As a graduate student, she developed an Artificial Transcription Factor library to interrogate transcriptional networks that control cell fate decisions under the mentorship of Aseem Ansari, PhD. During her postdoctoral research, she discovered that a telomere binding protein can rescue disease phenotypes of Duchenne muscular dystrophy in cardiomyocytes differentiated from patient-derived induced pluripotent stem cells. Dr. Eguchi is also developing gene therapies that address heart failure in Duchenne and Becker patients. She is a recipient of the Translational Research and Applied Medicine Award, the American Heart Association Postdoctoral Fellowship, and Muscular Dystrophy Association Development Grant.
-
Steven Higginbottom
Life Science Rsch Prof 4, Microbiology and Immunology
Current Role at StanfordMaintain and operate Gnotobiotic research facility.
-
Samantha M Kerath
Director of Finance and Administration, Microbiology and Immunology
Current Role at StanfordDirector of Finance & Administration
Microbiology & Immunology and Baxter Lab -
David McIlwain
Sr Res Scientist-Basic Life, Microbiology and Immunology - Baxter Labs
BioDr. McIlwain studies host-response to infectious disease using high dimensional single-cell and spatial proteomics tools. He trained for his Ph.D. at the University of Toronto exploring mouse biology using reverse genetics with renowned immunologist Dr. Tak W. Mak. His doctoral work yielded insights into alternative mRNA splicing and an important discovery about iRhom2 as a new factor controlling the production of inflammatory mediator TNF. As a post-doctoral fellow, Dr. McIlwain investigated host response to viral infection in animal models at the University of Dusseldorf in Germany before moving to Stanford University where along with Dr. Garry Nolan, he leads a team executing research contracted by the FDA’s medical countermeasures initiative to study emerging pathogens. This work includes mass cytometry (CyTOF) and spatial proteomic (CODEX) single-cell analysis of human and animal model influenza, Ebola, zika, and SARS-CoVs infections.
-
Alexandra Switzer
Basic Life Research Scientist, Microbiology and Immunology
Current Role at StanfordMicrobiologist, veterinarian and data analyst in the Relman lab studying the indigenous gut microbiota of a wide range of marine and terrestrial mammals. Current research interests include characterizing microbiome assembly in neonatal mammals, host-microbiome co-evolution and patterns of microbiome diversity associated with wildlife population health.
-
Hannah Constance Wastyk
Casual - Non-Exempt, Microbiology and Immunology
BioI am a PhD student in the Bioengineering Department working under Dr. Justin Sonnenburg. I am currently studying the microbiome and how it relates to the immune system in human studies through machine learning and statistical methods. I am also committed to creating opportunities and providing mentorship to students of diverse backgrounds.